Intra-Cellular Therapies, Inc.

Bedminster, NJ

UEI
VA5JXLCJHDK7
CAGE
3CQL3
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
135 US-202, Bedminster, NJ 07921, USA
Founded
2002
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Definitive Contract W81XWH06C0013 Medical Command (Army) $849,348

Grant awards

Award Agency Obligated Awarded
Development of ITI-333, a ?-opioid receptor partial agonist and 5HT2A and D1 receptor antagonist, for the treatment… UG3DA047699 National Institute on Drug Abuse (NIH) $12,000,352
Development of PDE2 inhibitors for treatment of anxiety/depression in autism/schizophrenia R43MH108209 National Institutes of Health $348,094
Casein kinase 1 inhibitors for treatment of autism R43MH102849 National Institutes of Health $318,905
Specific L type calcium channel antagonists for resistance to environmental triggers of neurodegeneration W81XWH0710054 Department of the Army $2,999,892
Synthesis and evaluation of novel pet net tracers R21MH074008 National Institutes of Health $154,510

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Intra-Cellular Therapies, Inc. registered in SAM.gov?

Yes. Intra-Cellular Therapies, Inc.'s SAM.gov registration is active through March 23, 2027.

What is Intra-Cellular Therapies, Inc.'s CAGE code?

Intra-Cellular Therapies, Inc.'s CAGE code is 3CQL3, and its Unique Entity ID (UEI) is VA5JXLCJHDK7.

Which contract vehicles does Intra-Cellular Therapies, Inc. hold?

Intra-Cellular Therapies, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Intra-Cellular Therapies, Inc.'s most recent federal award?

Intra-Cellular Therapies, Inc.'s most recent federal grant award is Development of ITI-333, a ?-opioid receptor partial agonist and 5HT2A and D1 receptor antagonist, for the treatment… (UG3DA047699), from National Institute on Drug Abuse (NIH), on January 1, 2019.

On GovTribe

See Intra-Cellular Therapies, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe